M. Treur

A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss

M. Treur, Bart Heeg, Hans‐Jürgen Möller et al. · BMC Health Services Research · 2009 · 31 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis

F. Pierotti, Ilaria Palla, M. Treur et al. · PLoS ONE · 2015 · 26 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Real-world Outcomes of Multiple Myeloma: Retrospective Analysis of the Czech Registry of Monoclonal Gammopathies

Roman Hájek, Jiří Jarkovský, Vladimír Maisnar et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 24 citations

Medicine, Hematology, Oncology +14

A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France

Kaspar Nieland, Antoine Labbé, Cédric Schweitzer et al. · PLoS ONE · 2021 · 23 citations · Full text

Pharmacy, Ophthalmology, Surgery +17

A cost utility analysis of simeprevir used with peginterferon + ribavirin in the management of genotype 1 hepatitis C virus infection, from the perspective of the UK National Health Service

K.Y. Westerhout, M. Treur, Angelika Mehnert et al. · Journal of Medical Economics · 2015 · 19 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17